Short answer
Dexcom (DXCM) filed an 8-K current report with the SEC on September 14, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). CFO Jereme Sylvain promoted to EVP, Chief Operating Officer and CFO, effective September 14, 2026.
Dexcom 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- CFO Jereme Sylvain promoted to EVP, Chief Operating Officer and CFO, effective September 14, 2026
- Expanded mandate combines financial leadership with operational oversight
- Annual base salary set at $767,000 with 75% target bonus opportunity
- Continued eligibility for equity awards and executive severance/change-in-control benefits
Item 7.01 · Regulation FD Disclosure
- Dexcom announced Mr. Sylvain’s promotion on September 14, 2026
- Promotion details and leadership implications appear in Exhibit 99.1 accompanying the filing
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Dexcom 8-K filings
Get the next DXCM 8-K as it lands
Follow DXCM for push alerts, or ask the research agent what this filing means.